Comparison of Efficacy of Low- (80 mg/day) and High- (160-320 mg/day) Dose Valsartan in the Prevention of In-Stent Restenosis after Implantation of Bare-Metal Stents in Type B2/C Coronary Artery Lesions

Author： Peters Stefan  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.8, Iss.2, 2008-01, pp. : 83-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-dose valsartan for prevention of in-stent restenosis

By  

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

A short course of sirolimus [rapamycin] substantially reduces the rate of restenosis after bare-metal coronary stent implantation

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

A randomised, double-blind, comparison of the efficacy and safety of venlafaxine (75 to 150 mg/day) versus fluoxetine (20 mg/day) in depressed outpatients

By Salinas E.   Nicholas T.   Hackett D.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 308-308

Elsevier

Access to resources Recommend Favorite

Sirolimus-eluting stents are more effective than bare stents for the prevention of coronary artery restenosis in patients with de novo lesions

By  

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Efficacy of Tamsulosin 0.4 mg/day in Relieving Double-J Stent-related Symptoms: a Randomized Controlled Study

By Navanimitkul N   Lojanapiwat B  

The Journal of International Medical Research, Vol. 38, Iss. 4, 2010-07 ,pp. : 1436-1441

Field House Publishing

Access to resources Recommend Favorite